검색어 : 통합검색[Orr Rebecca B.]
총 76건 중 76건 출력
, 6/8 페이지
-
51
- Abstract CT033: KontRASt-01: A phase Ib/II, dose-escalation study of JDQ443 in patients (pts) with advanced, KRAS G12C-mutated solid tumors
- Tan, Daniel S.; Shimizu, Toshio; Solomon, Benjamin; Heist, Rebecca S.; Schuler, Martin; Luken, Maria J. De Miguel; Gazzah, Anas; Wermke, Martin; Dooms, Christophe; Loong, Herbert H.; Steeghs, Neeltje; Felip, Enriqueta; Steuer, Conor E.; van Cutsem, Eric; Soo, Ross A.; Jaeger, Ashley C.; Kim, Jaeyeon; Xu, Kun; Chen, Xueying; Cui, Xiaoming; Burks, Heather; Farago, Anna; Cassier, Philippe A.; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.82, 2022, pp.CT033-CT033)
-
52
- Abstract CT028: A first-in-human phase 1 study of LY3537982, a highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C-mutant advanced solid tumors
- Murciano-Goroff, Yonina R.; Heist, Rebecca S.; Kuboki, Yasutoshi; Koyama, Takafumi; Ammakkanavar, Natraj Reddy; Hollebecque, Antoine; Patnaik, Amita; Shimizu, Toshio; Spira, Alexander I.; Nagasaka, Misako; Han, Ji-Youn; Iams, Wade Thomas; Deming, Dustin; Call, Justin; Cassier, Philippe; Han, Sae-Won; Siu-chung Chu, Quincy; Cosman, Rasha; Durm, Gregory; Burns, Timothy; Willard, Melinda D.; Liu, Shiyao; Callies, Sophie; Balar, Arjun V.; Sabari, Joshua K.; 1David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, NY; ; 2Massachusetts General Hospital Cancer Center, Boston, MA; ; 3Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan; ; 4National Cancer Center Hospital, Tokyo, Japan; ; 5Community Health Network, Indianapolis, IN; ; 6Gustave Roussy, Villejuif, France; ; 7START San Antonio, San Antonio, TX; ; 8Wakayama Medical University Hospital, Wakayama, Japan; ; 9NEXT Oncology, Fairfax, VA; ; 10University of California Irvine School of Medicine, Orange, CA; ; 11National Cancer Center, Gyeonggi-do, Republic of Korea; ; 12Vanderbilt University School of Medicine, Nashville, TN; ; 13Carbone Cancer Center; University of Wisconsin, Madison, WI; ; 14START Mountain Region, Salt Lake City, UT; ; 15Department of Medical Oncology, Centre Lé on Bé rard, Lyon, France; ; 16Seoul National University Hospital, Seoul, Republic of Korea; ; 17Alberta H; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.CT028-CT028)
-
53
- Abstract CT197: Phase Ib study of LXH254 + trametinib (TMT) in patients (pts) with <i>NRAS</i>-mutant melanoma
- de Braud, Filippo; Dooms, Christophe; Heist, Rebecca S.; Lebbe, Celeste; Wermke, Martin; Planchard, David; Schadendorf, Dirk; Rutkowski, Piotr; Wolf, Jü rgen; Ascierto, Paolo A.; Gil-Bazo, Ignacio; Kato, Shumei; Wolodarski, Maria; McKean, Meredith; Couselo, Eva Muñ oz; Sebastian, Martin; Santoro, Armando; Cooke, Vesselina; Manganelli, Luca; Wan, Kitty; Gaur, Anil; Samant, Tanay S.; Kim, Jaeyeon; Caponigro, Giordano; Couillebault, Xuâ n-Mai; Moschetta, Michele; Daud, Adil; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.82, 2022, pp.CT197-CT197)
-
54
- Abstract LB-36: Chemotherapy testing of primary human ovarian cancers in an ex vivo 3D culture platform: A novel method of phenotypic profiling for clinical trial selection and personalized medicine
- Shuford, Stephen; Widener, Rebecca; Cheluvaraju, Chaitra; Desrochers, Teresa; mattingly, christina; Puls, Larry; gevaert, matt; Orr, David; Crosswell, Hal E.; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.74, 2014, pp.LB-36-LB-36)
-
55
- Abstract CT008: A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) recurrent or persistent endometrial cancer
- Porter, Rebecca L.; Xiong, Niya; Tayob, Nabihah; Polak, Madeline; Sawyer, Hannah; Hayes, Martin; Gardner, Jeanette; Campos, Susana; Horowitz, Neil; Krasner, Carolyn; Lee, Elizabeth K.; Liu, Joyce F.; Stover, Elizabeth H.; Veneris, Jennifer; Wright, Alexi A.; Matulonis, Ursula A.; Konstantinopoulos, Panagiotis; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; 1Dana-Farber Cancer Institute, Boston, MA.; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.CT008-CT008)
-
56
- Pathogenesis of obstructive sleep apnea in people living with HIV
- Orr, Jeremy E.; Edwards, Bradley A.; Schmickl, Christopher N.; Karris, Maile; DeYoung, Pamela N.; Darquenne, Chantal; Theilmann, Rebecca; Jain, Sonia; Malhotra, Atul; Hicks, Charles B.; Owens, Robert L.; Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, San Diego, California; Sleep and Circadian Medicine Laboratory, Department of Physiology, Biomedicine Discovery Institute, Monash University, Melbourne, Australia; Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, San Diego, California; Division of Infectious Disease, University of California San Diego, San Diego, California; Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, San Diego, California; Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, San Diego, California; Department of Radiology, University of California San Diego, San Diego, California; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, San Diego, California; Division of Pulmonary, Critical Care, and Sleep Medicine, University of Califor; (Journal of applied physiology, v.131, 2021, pp.1671-1678)
-
57
- Abstract P5-11-01 : Phase 1 dose escalation study of a novel selective androgen receptor modulator (SARM), RAD140, in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-), metastatic breast cancer
- Hamilton, Erika; LoRusso, Patricia; Ma, Cynthia; Vidula, Neelima; Bagley, Rebecca G; Troy, Steven; Annett, Miriam; Yu, Ziyang; Weitzman, Aaron; Conlan, Maureen G; Weise, Amy; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.80, 2020, pp.P5-11-01-P5-11-01)
-
58
- Mechanism, Prevalence, and More Severe Neuropathy Phenotype of the Charcot-Marie-Tooth Type 1A Triplication
- Liu, P.; Gelowani, V.; Zhang, F.; Drory, Vivian E.; Ben-Shachar, S.; Roney, E.; Medeiros, Adam C.; Moore, Rebecca J.; DiVincenzo, C.; Burnette, William B.; Higgins, Joseph J.; Li, J.; Orr-Urtreger, A.; Lupski, James R.; ; (American journal of human genetics, v.94, 2014, pp.462-469)
-
59
- EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis
- Finney, Alexandra C.; Funk, Steven D.; Green, Jonette M.; Yurdagul Jr, Arif; Rana, Mohammad Atif; Pistorius, Rebecca; Henry, Miriam; Yurochko, Andrew; Pattillo, Christopher B.; Traylor, James G.; Chen, Jin; Woolard, Matthew D.; Kevil, Christopher G.; Orr, A. Wayne; From Departments of Cell Biology and Anatomy (A.C.F., S.D.F., J.M.G., A. Yurdagul, C.G.K., A.W.O.), Pathology and Translational Pathobiology (J.M.G., A. Yurdagul, R.P., M.H., J.G.T., C.G.K., A.W.O.), Cardiology (M.A.R.), Microbiology and Immunology (A. Yurochko, M.D.W.), and Molecular and Cellular Physiology (C.B.P., C.G.K., A.W.O.), Louisiana State University Health Sciences Center-Shreveport; Departments of Cancer Biology and Cell and Developmental Biology, Vanderbilt University, Nashville, TN (J.C.); and Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville (J.C.).; From Departments of Cell Biology and Anatomy (A.C.F., S.D.F., J.M.G., A. Yurdagul, C.G.K., A.W.O.), Pathology and Translational Pathobiology (J.M.G., A. Yurdagul, R.P., M.H., J.G.T., C.G.K., A.W.O.), Cardiology (M.A.R.), Microbiology and Immunology (A. Yurochko, M.D.W.), and Molecular and Cellular Physiology (C.B.P., C.G.K., A.W.O.), Louisiana State University Health Sciences Centerȁ (Circulation, v.136, 2017, pp.566-582)
-
60
- Sugar-Sweetened Beverages and Adverse Human Health Outcomes: An Umbrella Review of Meta-Analyses of Observational Studies
- Lane, Melissa M.; Travica, Nikolaj; Gamage, Elizabeth; Marshall, Skye; Trakman, Gina L.; Young, Claire; Teasdale, Scott B.; Dissanayaka, Thusharika; Dawson, Samantha L.; Orr, Rebecca; Jacka, Felice N.; O'Neil, Adrienne; Lawrence, Mark; Baker, Phillip; Rebholz, Casey M.; Du, Shutong; Marx, Wolfgang; 1Institute for Mental and Physical Health and Clinical Translation (IMPACT), Food & Mood Centre, School of Medicine, Deakin University, Barwon Health, Geelong, Victoria, Australia; email: m.lane@deakin.edu.au; 1Institute for Mental and Physical Health and Clinical Translation (IMPACT), Food & Mood Centre, School of Medicine, Deakin University, Barwon Health, Geelong, Victoria, Australia; email: m.lane@deakin.edu.au; 1Institute for Mental and Physical Health and Clinical Translation (IMPACT), Food & Mood Centre, School of Medicine, Deakin University, Barwon Health, Geelong, Victoria, Australia; email: m.lane@deakin.edu.au; 2Research Institute for Future Health, Gold Coast, Queensland, Australia; 5Department of Food, Nutrition, and Dietetics, Sport, Performance, and Nutrition Research Group, La Trobe University, Melbourne, Victoria, Australia; 1Institute for Mental and Physical Health and Clinical Translation (IMPACT), Food & Mood Centre, School of Medicine, Deakin University, Barwo; (Annual review of nutrition, v.44, 2024, pp.383-404)
QUICK MENU
